IO

Inning One Ventures

North America, New York, United States, New York

Description

Inning One Ventures is an early-stage life science venture capital firm.

Investor Profile

Inning One Ventures has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Medical.

Stage Focus

  • Series C (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Inning One Ventures frequently co-invest with?

Eli Lilly & Company Foundation
North America, Indiana, United States, Indianapolis
Co-Investments: 1
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
Goldman Sachs Asset Management
North America, New York, United States, New York
Co-Investments: 1
Schrödinger
North America, New York, United States, New York
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
NYU Langone Health
North America, New York, United States, New York
Co-Investments: 1
Point72 Ventures
North America, New York, United States, New York
Co-Investments: 1
Memorial Sloan - Kettering Cancer Center
North America, New York, United States, New York
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Inning One Ventures?

Ajax Therapeutics

Cambridge, Massachusetts, United States

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

BiotechnologyLife ScienceMedical
Series CMay 13, 2024
Amount Raised: $95,000,000
Ajax Therapeutics

Cambridge, Massachusetts, United States

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

BiotechnologyLife ScienceMedical
Series UnknownJun 1, 2021
Amount Raised: $40,000,000

Find More Investors Like Inning One Ventures

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Inning One Ventures | Pipeseed